ImmunoPrecise Antibodies Cash Flow Statement 2021-2024 | IPA

Fifteen years of historical annual cash flow statements for ImmunoPrecise Antibodies (IPA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2024202320222021
$-20.13$-19.98$-13.32$-5.62
$4.25$5.03$3.00$2.84
$10.98$2.50$1.94$3.09
$15.23$7.53$4.95$5.94
$-0.45$-0.42$0.13$-0.34
$-0.08$-0.14$-0.40$-0.24
$0$0$0$0
$1.01$0.02$-0.55$-0.92
$1.76$-2.46$0.46$-0.78
$-3.14$-14.92$-7.91$-0.46
$-1.03$-1.12$-0.85$-1.05
$0$0$-0.15$0
$0$0$-2.94$0
$0$0$0$0
$0.09$0.06$0$0
$0.09$0.06$0$0
$-0.21$-0.42$-0.21$-0.83
$-1.16$-1.48$-4.15$-1.88
$0$0$0$0.13
$-0.99$-1.01$-0.77$-0.72
$-0.99$-1.01$-0.77$-0.59
$1.75$0.54$3.07$33.78
$1.75$0.54$3.07$33.78
$0$0$0$0
$0$0$0.00$0
$0.76$-0.47$2.30$33.19
$-3.57$-16.31$-9.40$29.95
$1.14$1.46$2.46$2.10
$0$0$0$0